Navigation Links
Cochlear Americas Provides Support for Cochlear Implant Recipients to Pursue Higher Education

Company Announces 2009 Graeme Clark Scholarship Winners

DENVER, March 30 /PRNewswire/ -- Cochlear Americas, the world's leader in advanced hearing technologies, today announced the winners of the 2009 Graeme Clark Scholarship awards. Since 2002, the Graeme Clark Cochlear Scholarship Foundation has recognized the remarkable achievements of individuals who have received a Nucleus(R) cochlear implant - a small electronic device that can provide a sense of hearing to someone who has severe to profound hearing loss. This year, five outstanding students have been selected to receive a total of $40,000 in financial assistance toward an accredited university.

"Cochlear Americas is dedicated to empowering our Nucleus recipients with an opportunity to pursue higher goals and achieve their greatest dreams," said Chris Smith, President, Cochlear Americas. "We are proud to provide assistance to such intelligent and engaged young adults who demonstrate superior academic achievement, leadership and community involvement."

The five scholarship winners are:

  • Emily Fustos (Allison Park, PA), a freshman at Pennsylvania State University, was born profoundly deaf and received a Nucleus cochlear implant at age 2. Emily is enrolled in the Schreyer Honors College where she is considering using her unique perspective of both the deaf and hearing worlds to specialize in speech pathology and communication disorders.

  • Alison Marinelli (South Windsor, CT), a freshman at Assumption College, was diagnosed with profound hearing loss at the age of 9 months, and at age 4 received her first Nucleus cochlear implant. She received a second cochlear implant in her other ear as a teenager. She is pursuing a degree in speech and language pathology, with the ultimate goal of attaining both her master's and doctorate degrees to better assist others in developing skills in hearing and oral communication.

  • Heather Page (Fairfield, OH), a sophomore at the University of North Carolina at Wilmington, was diagnosed with severe-to-profound hearing loss at age 3 and received a Nucleus cochlear implant when she was 16. Heather is working toward a degree in marine biology and environmental studies within the nationally-recognized marine biology program at UNCW, and pursuing her passion for music as concert master of the clarinet section in the UNCW Wind Symphony.

  • Grayson Swaim (Camby, IN), a freshman at Wabash College, became deaf from bacterial meningitis when he was 10 months old and received a Nucleus cochlear implant at age 5. Grayson believes his cochlear implant helped him to achieve his goals of graduating from high school with honors and getting accepted into a four-year university. Grayson hopes to pursue a career in law and make a difference in people's lives by creating more opportunities for those in need.

  • Tyler Wagner (Ackley, IA), a sophomore at University of Northern Iowa, lost his hearing after a tragic trampoline accident in 1998. Shortly after the accident, he received a Nucleus cochlear implant. Tyler excelled in athletics in high school, placing sixth in the Iowa State Wrestling Tournament his senior year. Tyler is currently pursuing a degree in exercise science and looks forward to having a positive impact on the health of others.

The winners were announced at an award ceremony held March 29 as part of Cochlear Americas' Celebration 2009. This inspirational four-day event offers educational sessions and a variety of activities designed to unite the Cochlear community of recipients, volunteers and their families to share experiences and successes. Celebration is the largest gathering of cochlear implant recipients in the world, bringing together more than 600 recipients and their families.

For 2009, Cochlear Americas received 80 scholarship applications from students in 27 states across the U.S. and five provinces in Canada. Eligible students must have a Nucleus cochlear implant and must be entering their first year of college or enrolled in an accredited university. Selection criteria include academic performance, letters of recommendation, awards and activities, and a short personal essay describing academic inspiration and other interests. Past winners of the scholarship have gone on to achieve great success, including graduating college with honors, playing collegiate-level sports and pursuing graduate degrees in medicine and law. Brief biographies of the 2009 scholarship winners are available online at

About Cochlear Americas

Cochlear Americas is the world's leader in advanced hearing technologies. Since launching the first multichannel cochlear implant system more than 25 years ago, Cochlear Limited and its U.S. headquarters have brought the miracle of sound to more than 150,000 hearing-impaired individuals across the globe. Cochlear Americas' state-of-the-art cochlear implant technology, based on extensive research and development at preeminent academic institutions, provides the ability to hear sound and better understand speech, enhancing both learning capabilities and quality of life for those with severe-to-profound hearing loss. Cochlear Americas also markets an implantable bone-anchored hearing device for treatment of conductive and mixed hearing loss, as well as single-sided deafness. For more information about Cochlear Americas' products, call the Cochlear Hotline at 800/458-4999 (Voice) or 800/483-3123 (TTY) or visit

About the Graeme Clark Cochlear Scholarship Foundation

The Graeme Clark Cochlear Scholarship Foundation was established in 2002 in honor of Professor Graeme Clark, Department of Otolaryngology at the University of Melbourne, for his lifelong commitment to finding a solution for the hearing impaired and his pioneering work in the field of cochlear implant technology. Awarded by Cochlear Americas, this scholarship consists of financial assistance towards a college degree at an accredited university. The award is paid in yearly installments upon the completion of each year of study. Each award is in the amount of $2,000 per year for up to a total of four years. For more information about the Graeme Clark Cochlear Scholarship Foundation, call 800/458-4999 (Voice) or 800/483-3123 (TTY), or visit

About Cochlear Implants

A cochlear implant is an electronic device that is surgically implanted and works by directly stimulating functioning auditory nerve fibers in the inner ear. Unlike hearing aids, cochlear implants do not amplify sound, but instead are designed to mirror natural hearing. Cochlear implants convert sound waves to electrical impulses and transmit them to the inner ear, providing people with severe-to-profound hearing loss the ability to identify sounds in their environment and often to understand speech without reading lips. The cochlear implant is recognized as a standard treatment for profound deafness by the American Medical Association and the American Academy of Otolaryngology -- Head and Neck Surgery. For more information about cochlear implants, visit

SOURCE Cochlear Americas
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants
2. Abbott to Present at UBS Best of Americas Investment Conference
3. DaVita to Present at UBS Best of Americas Conference
4. Nile Therapeutics Provides Update on Phase II CD-NP Clinical Trial for Acute Heart Failure
5. Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update
6. Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
7. OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
8. FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product
9. In Analyst Interview, Cord Blood America Provides Details of Special Shareholder Meeting
10. Zogenix Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM)
11. Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009.
Post Your Comments:
(Date:11/24/2015)... N.J. (PRWEB) , ... November 24, 2015 , ... The ... the recipient of the 2016 USGA Green Section Award. Presented annually since 1961, the ... through his or her work with turfgrass. , Clarke, of Iselin, N.J., ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... event of the year and one of the premier annual events for pharmaceutical ... ran from 8–11 November 2015, where ISPE hosted the largest number of attendees ...
(Date:11/24/2015)... ... 2015 , ... The Academy of Model Aeronautics (AMA), led by its Executive ... Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. , FPV racing ... this type of racing and several new model aviation pilots have joined the community ...
(Date:11/24/2015)... 24, 2015  Twist Bioscience, a company focused ... Ph.D., Twist Bioscience chief executive officer, will present ... December 1, 2015 at 3:10 p.m. Eastern Time at The ... --> --> ... Bioscience is on Twitter. Sign up to follow ...
Breaking Biology Technology:
(Date:11/12/2015)... Mass. , Nov. 12, 2015  Arxspan ... Institute of MIT and Harvard for use of ... discovery information management tools. The partnership will support ... both biological and chemical research information internally and ... will be used for managing the Institute,s electronic ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):